Temasek Holdings

Temasek Holdings is a Singapore-based investment company founded in 1974. The firm specializes in providing debt financing and is dedicated to transforming economies, enhancing middle-income populations, and fostering emerging champions. Temasek operates across various sectors, including financial services, transportation, industrial, consumer goods, real estate, telecommunications, media, technology, and life sciences. Its strategic focus is on developing comparative advantages within these industries to support sustainable growth and innovation.

Pradyumna Agrawal

Director

Soyoun Ahn

Managing Director, Investment (Credit and Hybrid Solutions)

Gary Ang

Managing Director, Macro Strategy

Parimal Aswani

Managing Director, Technology

Ravi Balasubramanian

Managing Director, Portfolio Development, New Energy and Industrials

Siddartha Bhattacharjee

Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group

Eric Bielke

Director

Dawn Chan

Director of Investments

Yuliang Chang

Managing Director, Investment (China)

Eu Chua

Managing Director, Institutional Relations and Singapore Market

Ranjit Dandekar

Managing Director, Investment

Nagi Hamiyeh

Senior Managing Director

Reena Kanagasingam

Managing Director, Investment (Public Markets)

Ming Pey Lim

Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office

Paul Liu

Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group

Anuj Maheshwari

Head, Agri-Food Managing Director, Investment (Middle East and Africa)

Nicolas Meier

Managing Director, Investment (EMEA) and Director

Jingwen Miao

Managing Director, Investment (China)

Suranjan Mukherjee

Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies

Ryan Rakestraw

Director

Parangam Ray

Managing Director, Organisation and People

Pierce Scranton

Managing Director, Institutional Relations and Deputy Head, North America

Shaun Seow

Managing Director, Singapore Market and Head, Community Stewardship

Jason Sun

Chief Representative, Beijing and Managing Director, Investment (China)

Belinda Tan

Managing Director, Finance (Financial Management)

Man-Keung Tang

Managing Director, Macro Strategy

Sulian Tay

Operating Partner

Karen Toh

Managing Director, Finance (Treasury)

Damien Vacherot

Director

Benoit Valentin

Senior Managing Director EMEA and Head of Private Equity Fund Investments

Rob Williams

Managing Director, Investment (EMEA)

Yibing Wu Ph.D

CEO, China

Past deals in Series C

Fortera

Series C in 2024
Fortera is focused on developing innovative cement products that significantly reduce carbon dioxide emissions associated with concrete production. The company has created a process that captures industrial carbon emissions and mineralizes them to produce a less carbon-intensive form of concrete. This method not only aims to lower the environmental impact of construction but also enhances the performance characteristics of their products compared to traditional concrete. By providing a more sustainable alternative, Fortera contributes to the global effort to mitigate greenhouse gas emissions, addressing a critical challenge in the construction industry.

Nearfield Instruments

Series C in 2024
Nearfield Instruments B.V., founded in 2016 and based in Rotterdam, the Netherlands, specializes in the development and manufacture of High-Throughput Scanning Probe Metrology systems tailored for advanced integrated circuit metrology. The company’s technology employs atomic-scale probes to scan and analyze the surfaces of semiconductor samples, facilitating atomic-scale resolution during the fabrication process. This innovative approach enhances process control in semiconductor manufacturing, leading to improved production yields and functionality of microchips. By supporting the advancement of smaller and more efficient electronic devices, Nearfield Instruments plays a crucial role in the evolution of the semiconductor industry.

Celestial AI

Series C in 2024
Celestial AI is a machine learning accelerator company focused on developing an advanced optical interconnect technology platform for data centers and AI applications. By leveraging photonics, mixed-signal ASICs, and innovative packaging techniques, the company aims to enhance computing performance sustainably. Its proprietary Photonic FabricTM serves as the core technology for creating optically scalable and disaggregated data center computing and memory systems. This technology is designed to enable significant advancements in artificial intelligence, allowing clients to provide superior AI acceleration hardware and software solutions.

Skyroot Aerospace

Series C in 2023
Skyroot Aerospace is an aerospace manufacturer and launch service provider based in Hyderabad, India, established in 2022. The company focuses on developing launch vehicles aimed at providing cost-effective access to space, primarily for small satellites. By building technologies that enhance the reliability, responsiveness, and economics of space launches, Skyroot Aerospace seeks to make spaceflight as regular and affordable as air travel. Their mission is to enable businesses and organizations to access space more frequently and economically, thereby expanding opportunities in the burgeoning space industry.

Metropolis

Series C in 2023
Metropolis is an artificial intelligence and computer vision start-up founded in 2017 and based in Los Angeles, California. The company focuses on modernizing parking and enhancing future mobility solutions. Its operating platform utilizes advanced computer vision technology to create a modern mobility commerce infrastructure that aims to improve revenue generation and lower operating expenses for real estate partners. This system enables asset owners to optimize net operating income while providing access to contemporary parking amenities and diverse mobility options.

Electric Hydrogen

Series C in 2023
Electric Hydrogen is a company focused on developing low-cost, high-efficiency, fossil-free hydrogen systems aimed at decarbonizing industrial sectors such as ammonia and steel production, which are significant contributors to global greenhouse gas emissions. By rethinking electrolysis, Electric Hydrogen seeks to make clean hydrogen competitive with traditional, fossil-fuel-based hydrogen in terms of cost and scalability. The company's advanced PEM technology utilizes low-cost renewable electricity to produce clean hydrogen gas, thereby helping industries reduce their reliance on fossil fuels and minimize pollution. With a leadership team experienced in transformative clean energy companies, Electric Hydrogen is positioned to address current challenges in efficiency and cost, contributing to the goal of a zero-emission industrial sector in the near future.

TeraWatt Technology

Series C in 2023
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, specializes in the design and development of lithium-ion rechargeable batteries for various electrified applications. The company focuses on producing batteries that combine energy and power density with safety, catering to the needs of industrial clients. Through advanced engineering practices and efficient production processes, TeraWatt Technology aims to provide long-lasting, safe, and reliable power alternatives, supporting a wide range of electrification initiatives. Additionally, TeraWatt has a subsidiary located in Tokyo, Japan, further expanding its reach in the global market.

Atomberg

Series C in 2023
Atomberg Technology is a manufacturer of smart and energy-efficient household appliances, focusing on reducing power consumption. The company's product range includes ceiling fans, pedestal fans, table fans, and wall-mounted fans. These appliances are equipped with smart remote controls and advanced features such as timer mode, sleep mode, and boost mode, which enhance user convenience and comfort. Atomberg aims to disrupt the appliance market by integrating energy efficiency with innovative technology, offering customers intelligent solutions that not only improve their living environments but also contribute to cost savings on energy bills.

Foretellix

Series C in 2023
Foretellix Ltd. is a company based in Tel Aviv, Israel, focused on developing a verification framework for Intelligent Autonomous Systems, particularly in the realm of Autonomous Vehicles. Founded in 2010, Foretellix offers solutions that automate the safety verification of complex automated driving systems, addressing the challenges of risk, cost, and time to market. The company has created a platform that automates the analysis of safety-related coverage metrics, ensuring that vehicles perform correctly across a wide range of driving scenarios. This platform enables comprehensive coverage verification services, which are essential for confirming the safety and reliability of autonomous vehicles prior to their deployment. Additionally, Foretellix has developed a standardized language for describing autonomous vehicle scenarios, further enhancing its contributions to the field of automotive safety verification.

Einride

Series C in 2022
Einride is a freight technology company founded in 2016, specializing in digital, electric, and autonomous shipping solutions. In 2019, it became the first company globally to operate an autonomous electric freight vehicle on public roads. Einride designs and manufactures advanced transportation vehicles that utilize all-electric technology, complemented by intelligent routing software. This software integrates customer and traffic data to optimize delivery times, battery life, and energy consumption. The company's technology allows for remote control of vehicles, providing users with a safe, emission-free, cost-effective, and sustainable freight mobility option. Additionally, Einride offers tools for users to manage electrification and automation, track shipments, oversee routes, and visualize data for enhanced operational insights.

Trigo

Series C in 2022
Trigo is a technology company focused on enhancing the retail experience through its AI-powered infrastructure. It develops a retail automation platform that facilitates checkout services in grocery stores. The platform provides features such as anonymous shopper tracking, detection of interactions with products, product classification, and automatic data annotation. By leveraging deep learning architecture, Trigo enables retail stores to utilize advanced artificial intelligence technology, resulting in an automated and streamlined checkout process for customers.

Fi.Money

Series C in 2022
Fi is a financial app that comes with an in-built savings account. Emboldened by cutting edge tech, Fi helps its users know their money, grow their money, and organize their funds. Users access Fi's Savings Account & VISA debit card, through its partnership with RBI-licensed Federal Bank.

Whale

Series C in 2022
Whale provides an omnichannel marketing platform that transforms marketing operations, digitalizes store operations and unifies offline & online brand experiences leveraging AI + IoT + Big Data to “Connect Brands with Customer”. Founded in 2017, Whale has since empowered 1000+ global FMCG, F&B, Fashion and Automotive brands including P&G, Unilever, Starbucks, UNIQLO, ARMANI, Watsons, Xiaomi, Midea, Lotus, POP MART etc. with over 150,000 stores across APAC, enabling brands to embrace the full potential of digital transformation. Equipped with AI capabilities, patented ReID technology and enterprise-grade security, Whale platforms comprising of Space Data Platform (SDP), Whale Marketing Cloud (WMC), Whale Open Platform (WOP) and Whale Analytics, serve as the end-to-end digitalization engine that enables brands to seamlessly engage with each customer. Whale is backed by Temasek Holding, NIO Capital, Source Code Capital, Linear Capital, Alpha Commune, BAI Capital and The Jiangmen, with 6 offices across Singapore, Hangzhou, Shanghai, Beijing and Shenzhen.

UPSIDE Foods

Series C in 2022
UPSIDE Foods, founded in 2015 and based in Berkeley, California, specializes in the production of cultivated meat derived directly from animal cells, eliminating the need to raise and slaughter animals. This innovative approach allows the company to offer real meat, poultry, and seafood while significantly reducing the resource consumption typically associated with conventional meat production, including water, land, and energy. UPSIDE Foods focuses on creating products such as beef meatballs, chicken, and duck, all grown in controlled environments. The company's mission is to provide consumers with clean, humane, and sustainable food options, free from harmful chemicals.

AutoBrains

Series C in 2022
AutoBrains is a developer of a visual intelligence platform designed to enhance the safety and effectiveness of autonomous driving services. The platform leverages advanced artificial intelligence, employing signature-based representation structures and unsupervised learning methodologies to create a detailed understanding of the vehicle's surroundings. This technology supports various applications, including advanced driver assistance systems and vehicle localization, ultimately aiming to improve car safety and reduce casualties on global roadways. With a foundation of over 200 patents, AutoBrains' self-learning technology represents a significant advancement in automotive visual intelligence.

Immutable Systems

Series C in 2022
Immutable develops blockchain-based eSport games designed to familiarize users with blockchain technology in a fun and user-friendly environment. Its eSports games use ethereum blockchain to transform digital asset ownership in the video-gaming industry. Immutable provides scalable blockchain infrastructure for video games, enabling organizations to bring transparency in the opaque world of in-game economies.

FTX

Series C in 2022
FTX Exchange is a cryptocurrency exchange that offers a platform designed for both professional trading firms and novice users. It provides a range of products, including quarterly and perpetual futures for various cryptocurrencies, leveraged tokens, and over-the-counter trading. The exchange was initially developed by Alameda Research, a leading provider of cryptocurrency liquidity, which contributed to its robust market presence from the outset. Additionally, FTX Ventures served as the corporate venture capital arm of FTX, investing in various sectors such as healthcare, information technology, and gaming. Founded in 2022, FTX Ventures aimed to support innovative startups without imposing restrictions on their decision-making processes. However, the company declared bankruptcy in November 2022, marking a significant downturn in its operations.

eFishery

Series C in 2022
eFishery is an aquaculture technology startup that focuses on providing innovative solutions for fish and shrimp farmers. The company develops smart feeding systems equipped with motion sensors to assess fish appetite and optimize feed amounts, thereby enhancing productivity and sustainability in aquaculture. Additionally, eFishery offers a cloud-based dashboard and data platform that supports farmers in managing their operations effectively. By integrating services such as farming operations, financing, and distribution, eFishery addresses key challenges in the aquaculture industry, aiming to reduce social and economic inequalities while promoting a more sustainable and equitable environment for fish and shrimp farming.

Sarvagram

Series C in 2022
SarvaGram Fincare Private Limited is a fintech startup based in Mumbai, India, that provides financial services to individuals and small enterprises in rural and semi-urban areas. Founded in 2018, the company offers a range of loan products, including gold loans, consumer durable loans, farm loans, and business loans. By leveraging a data science-enabled platform, SarvaGram assesses the financial potential of rural households, treating them as cohesive economic units. The company's approach incorporates a comprehensive understanding of household cash flows, balance sheets, and various income streams. In addition to credit services, SarvaGram facilitates access to productivity-enhancing tools and risk management solutions, thereby supporting livelihood upgrades for underserved communities and enabling small to medium businesses to secure necessary financing.

Ola Electric

Series C in 2021
Ola Electric Mobility, founded in May 2017 by Ankit Jain and Anand Shah, is headquartered in Bengaluru, India. The company specializes in electric vehicles (EVs) and is focused on creating a vertically integrated ecosystem for manufacturing EVs and core components like battery packs, motors, and vehicle frames at its Ola Futurefactory. Ola Electric aims to enhance the adoption of electric mobility in India by providing reliable and affordable transportation solutions, including shared daily mobility through leasing electric cars. In addition to its domestic focus, the company is exploring opportunities to export its EVs to select international markets, aiming to capitalize on the growing demand for electrification in the mobility sector.

The EVERY Company

Series C in 2021
The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animal agriculture with a more sustainable, kinder, and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.

Carro

Series C in 2021
Carro is an automotive marketplace that offers a full-stack service for all aspects of car ownership. It challenges the traditional way of buying and selling of cars through a proprietary pricing algorithm. Carro also provides a range of services that offer everything a car owner needs throughout their car ownership journeys such as an in-house financing solution warranty options and Singapore’s first on-demand roadside recovery platform. The company was founded in 2015 and is headquartered in Singapore.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. was founded in Longgang, Shenzhen, China on May 4, 2017. It is committed to researching and promoting most advanced smart equipment in the world,polishing the ultimate product with the spirit of pursuing excellence and fineness, improving surgical safety and treatment efficacy, and contributing to uprising the level of social health.

AutoBrains

Series C in 2021
AutoBrains is a developer of a visual intelligence platform designed to enhance the safety and effectiveness of autonomous driving services. The platform leverages advanced artificial intelligence, employing signature-based representation structures and unsupervised learning methodologies to create a detailed understanding of the vehicle's surroundings. This technology supports various applications, including advanced driver assistance systems and vehicle localization, ultimately aiming to improve car safety and reduce casualties on global roadways. With a foundation of over 200 patents, AutoBrains' self-learning technology represents a significant advancement in automotive visual intelligence.

Memed

Series C in 2021
Memed is a developer of a digital prescriptions platform that provides web-based e-prescribing services to healthcare professionals. The platform is designed to enhance treatment adherence for patients by offering smart prescriptions informed by a comprehensive database. It connects doctors with key partners in the healthcare industry, facilitating effective communication and collaboration. This approach aims to improve the quality of care by enabling doctors to deliver accurate prescriptions and treatment plans tailored to individual patient needs. Memed emphasizes safety and user-friendliness in its tools, making it an accessible option for both healthcare providers and patients.

NICK’S

Series C in 2021
NICK’S is a food tech company that manufactures keto diet-friendly ice cream, snack bars, and ice cream sandwiches. The company creates food products with the goal of revolutionizing the market for healthy snacks and sweets.

Fabric

Series C in 2021
Fabric operates an on-demand supply chain network platform designed to enhance retail delivery services, allowing for sustainable and rapid delivery options, including same-day and one-hour services. The company utilizes micro fulfillment centers equipped with robotics and artificial intelligence to automate various order preparation processes such as inventory reception, order picking, and packing. By positioning these local inventory hubs close to end-customers, Fabric enables retailers to improve their customer experience while maintaining profitable unit economics. Founded in 2015 and based in Tel Aviv, Israel, Fabric aims to drive revenue and customer loyalty for retailers through advanced software and automation, ultimately fostering greater operational efficiency and lower costs.

Orca Security

Series C in 2021
Orca Security Ltd. is a provider of a cloud-native security platform designed to secure both modern and legacy applications transitioned to the cloud. Founded in 2019 and headquartered in Tel Aviv, Israel, the company offers a solution that integrates directly into the cloud infrastructure, allowing it to assess the security state of every asset without the need for agents. This platform provides visibility into compromised resources, vulnerable software, and misconfigurations across various cloud environments, including AWS, Azure, and Google Cloud Platform. By utilizing read-only access, Orca ensures that its security assessments do not impact performance or availability. The platform aims to simplify cloud security by delivering comprehensive visibility and compliance, enabling organizations to identify critical vulnerabilities and mitigate risks effectively without relying on multiple disparate tools.

Momenta

Corporate Round in 2021
Momenta is an autonomous driving startup operating out of Beijing. Its deep-learning-based software in perception, HD semantic mapping, and data-driven path planning enables the realization of full autonomy. Momenta offer multi-level autonomous driving solutions as well as big data products and services. Momenta’s team is composed of experts in computer vision and deep learning, including one of the authors of Faster R-CNN and ResNet, the most popular deep learning network, as well as winners of ImageNet 2015, MS COCO Challenge 2015, and ImageNet 2017. The company is leading the autonomous driving software space with advanced technical competence and a strong commitment to innovation.

Allay Therapeutics

Series C in 2021
Allay Therapeutics is focused on developing innovative pain management solutions aimed at improving post-surgical recovery for patients. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutic products. These products are designed to deliver targeted pain relief at the surgical site over extended periods, significantly longer than conventional pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical trial for total knee arthroplasty surgeries. With a team of experienced entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics is dedicated to transforming the approach to pain management and addressing the limitations associated with opioid use.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals company based in Houston, Texas, that focuses on producing industrial chemicals through industrial biotechnology and green chemistry. Founded in 2016, Solugen develops a range of environmentally friendly products, including BioPeroxide, a carbon-negative hydrogen peroxide, and BioChelate, a biodegradable chelant. The company also offers ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, an alternative to phosphonates for scale control; and CorrSol, a corrosion and fouling control product. By utilizing fermentation and enzymatic technology to convert plant sugars into chemicals, Solugen aims to replace petroleum-based products with plant-derived alternatives. Its innovative solutions are designed to benefit various industries, including agriculture, cleaning, energy, and water, while also addressing critical issues such as clean water, sustainable materials, and healthier personal care products.

Open Financial Technologies

Series C in 2021
Open is Asia’s first neobanking platform for SMEs that is fast changing the way businesses bank & manage their finances. At Open, we help SMEs run everything right from their banking, payments to accounting, & expense management — together. This way they can focus on doing things that matter the most — grow their business. We’re home to some of the smartest & brightest 250+ minds in the fintech space. We’re a tight-knit tribe of creators and makers who are shaking up the way business banking rolls for over 10,00,000 businesses. We’re backed by some of the leading global VC firms like Tiger Global, Speedinvest, Beenext, AngelList, Recruit, Tanglin Venture Partners, 3one4 Capital, Unicorn India Ventures to name a few.

Oviva

Series C in 2021
Oviva UK Limited is a healthcare company based in London that specializes in digitally-enabled behavior change programs focused on diet and lifestyle-related health conditions, particularly type 2 diabetes and obesity. Founded in 2015, Oviva has developed a unique platform that combines a smartphone app and learning portals to provide personalized coaching and nutritional advice. This approach allows patients to engage in behavior change without the need for in-person clinic visits, thereby improving health outcomes and reducing costs for healthcare systems by preventing complications associated with these conditions. By leveraging a network of qualified consultants, Oviva aims to support individuals in achieving better health through tailored interventions.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

Covariant

Series C in 2021
Covariant is a developer of artificial intelligence for robotics. Covariant is building the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them.

iCapital Network

Series C in 2021
iCapital Network is a fintech platform for alternative investments and investors. It has transformed the way the wealth management, banking, and asset management industries facilitate access to private markets investments for their high-net-worth clients by providing intuitive, end-to-end technology and service solutions. Wealth management firms use iCapital’s solutions to provide clients with quality funds at lower minimums and simplified digital workflows. Asset managers, RIAs, and banks leverage iCapital’s technology to streamline and scale their alternative investments operational infrastructure. Additionally, the iCapital ‘flagship’ platform offers wealth advisors and their high-net-worth client's access to a curated menu of private equity, private credit, hedge funds, structured investments, and other alternatives to help meet their investing needs for return and diversification. iCapital’s research and diligence team offers robust analysis alongside the firm’s extensive suite of advisor education, compliance, portfolio management, and portfolio analytics tools and services. iCapital has been recognized on the Forbes FinTech 50 list each year from 2018 through 2002, the Forbes America’s Best Startup Employers in 2021 and 2022, and MMI/Barron’s Industry Awards as Solutions Provider of the Year in 2020 and 2021. As of May 31, 2022, iCapital services more than US$130 billion in global client assets, of which more than US$30 billion are from international investors (non-US Domestic), across more than 1,035 funds. Employing more than 800 people globally, iCapital is headquartered in NYC and has offices worldwide including in Zurich, London, Lisbon, Hong Kong, Singapore, and Toronto.

Orient Speech Therapy

Series C in 2021
Orient Speech Therapy Center is a professional organization focused on enhancing children's speech and mental development. It specializes in providing speech and language therapy services for children with speech disorders, including those with autism. The center offers early screening, clinical diagnosis, and therapeutic interventions to support improved communication skills. To facilitate this development, Orient Speech Therapy has designed comprehensive curriculums, including the Star Curriculum, which targets children's speech, social skills, phonics, and oral muscle exercises. Through these tailored programs, the center aims to help children overcome communication challenges and foster their overall growth.

Bowery Farming

Series C in 2021
Bowery Farming Inc. is a modern farming company based in New York that specializes in post-organic produce, offering products such as baby kale, lettuce, arugula, and basil. Founded in 2014, Bowery aims to revolutionize agriculture by using technology to create ideal indoor farming conditions. Its proprietary software, BoweryOS, integrates vision systems, automation, and machine learning to monitor and optimize plant growth continuously. This controlled environment allows Bowery to produce food using zero pesticides and 95% less water, achieving over 100 times the productivity of traditional farming on the same land footprint. Bowery's produce is available in select grocery stores, including Whole Foods and Foragers, and is featured on the menus of renowned restaurants in New York.

Oura

Series C in 2021
Oura is a Finland-based company that specializes in developing a smart wellness ring designed to monitor and track various biometric data related to health and wellness. The ring, paired with a smartphone application, enables users to gain insights into their sleep patterns, readiness, and activity levels. By utilizing advanced sensors, the device collects information on heart rate, sleep cycles, and overall activity, providing users with valuable physiological and behavioral data. This innovative approach supports individuals in understanding their body's responses to rest, recovery, and daily activities, thus promoting a healthier lifestyle.

Abiochem Biotechnology

Series C in 2021
Abiochem Biotechnology is a high-tech enterprise with leading enzyme engineering technology and genetic engineering technology. Engaged in the research and development of biocatalytic and synthetic biology methods, and is committed to its application to large-scale production. It is widely used in the fields of medicine, health care products, pesticides, etc., and has contributed to the promotion and development of green chemistry.

Halodoc

Series C in 2021
PT HaloDoc is a digital healthcare platform based in Jakarta, Indonesia, founded in 2016. It connects patients with a network of 19,000 licensed doctors and 1,000 certified partner pharmacies through its services. Users can engage with medical professionals via video calls, voice calls, and chat, making healthcare more accessible. The platform also allows patients to order laboratory tests that can be conducted at home. Additionally, HaloDoc helps users locate the nearest hospitals and clinics, streamlining the process of obtaining medical advice and services in real-time.

Hazel Technologies

Series C in 2021
Hazel Technologies, Inc. is a biotechnology company focused on reducing waste in the agricultural supply chain through innovative packaging solutions. Founded in 2015 and headquartered in Chicago, Illinois, with an additional location in Salinas, California, the company designs packaging inserts, known as sachets, that are placed in produce boxes at harvest. These sachets slow down the aging process of fruits and vegetables by controlling the storage atmosphere and inhibiting ethylene, which helps to extend shelf life and prevent spoilage. Hazel Technologies also offers horticultural consulting services to growers and shippers, working to improve the efficiency of the fresh produce supply chain. Their product development is supported by the United States Department of Agriculture, with performance validated by third-party research institutions. By providing effective shelf-life extension technologies and services, Hazel Technologies aims to combat global food waste and enhance profitability for its customers.

Genki Forest

Venture Round in 2021
Genki Forest is a beverage company specializing in sugar-free and low-calorie drinks, catering to health-conscious consumers seeking flavorful options. The company manufactures a range of products, including sugar-free tea and flavored seltzer water, produced from natural ingredients. By focusing on health and affordability, Genki Forest aims to provide accessible beverage choices that meet the demands of a growing market interested in healthier lifestyles.

NewMed Medical

Series C in 2021
NewMed Medical is a Shanghai-based medical device supplier, engaged in developing and procuding interventional artificial heart valve systems.

Tezign

Series C in 2021
Tezign is a content and AI-focused company founded in 2015, specializing in generative AI for enterprise content management. It develops digital infrastructure that enhances the production, management, distribution, and analysis of content for leading global enterprises. Tezign has collaborated with over 200 prominent companies, including Alibaba, Unilever, and McDonald's, and has produced more than 150,000 content assets, establishing a robust content asset management system. The company leverages advanced data technology and image recognition to connect top designers with businesses, providing essential tools for marketing content production and optimization. Tezign's content ecosystem comprises over 100,000 content creators, supporting its mission to improve content experiences for enterprises worldwide.

insitro

Series C in 2021
Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Clover Biopharmaceuticals

Series C in 2021
Clover Biopharmaceuticals is a clinical-stage biotechnology company dedicated to discovering, developing, and commercializing innovative biologic therapies primarily targeting oncology and autoimmune diseases. The company employs its proprietary Trimer-Tag technology platform to create novel biologics that focus on trimerization-dependent pathways. In addition to its therapeutic efforts, Clover is also engaged in the development of select biosimilars, utilizing its in-house cGMP biomanufacturing capabilities. The company aims to address unmet medical needs in both infectious diseases and cancer through its advanced vaccine and therapeutic candidates.

Black Lake Technologies

Series C in 2021
Black Lake Technologies is a fast-growing and venture-backed company, revolutionizing manufacturing enterprises with mobile-, IoT- and web-based collaboration platforms that acquire, visualize, monitor and analyze real-time manufacturing data. We enable factory staff (from top management to assembly line workers) to conveniently collaborate, interpret data, extract insights, and take immediate actions. The compoany's clients range from medium-sized enterprises to Fortune 500 conglomerates, whose production is made easier by Black Lake. Its investors include GSR, BAI, GGV, ZhenFund, China Growth Capital and IDG, with over CNY 100 million funding raised to date.

Provivi

Series C in 2020
Provivi Inc. specializes in developing biopesticides aimed at pest management in agriculture, commercial sectors, households, and public health. The company's innovative approach focuses on using insect pheromones, which provide a safe, environmentally friendly alternative to traditional pesticides. By leveraging biocatalysis technology initially developed at the California Institute of Technology, Provivi enhances the synthesis of these biopesticides, ensuring they are effective and free from toxic residues. Founded in 2013 and based in Santa Monica, California, the company collaborates with distributors worldwide to deliver its products, which are designed to protect food supplies sustainably and affordably. With a team of experienced professionals from biotechnology and the agricultural chemicals industry, Provivi is positioned to transform pest management practices through its advanced biological processes.

Form Energy

Series C in 2020
Form Energy, Inc. specializes in the development of long-duration energy storage systems aimed at enhancing the reliability of renewable energy sources such as wind and solar. Founded in 2017 and based in Somerville, Massachusetts, the company focuses on creating low-cost battery systems, including its innovative iron-air battery technology, which allows for energy storage over extended periods. This capability enables the dispatch of renewable energy throughout the year, effectively replacing traditional fossil fuel-based generation and contributing to the decarbonization of the electric grid. Additionally, Form Energy offers Formware, a capacity expansion software tool designed to optimize energy management. The company's technological advancements are rooted in research from MIT and are supported by various investors committed to sustainable energy solutions.

Gracell Biotechnologies

Series C in 2020
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing cell therapies for cancer treatment. The company’s lead product candidates include GC012F, a dual-target autologous CAR-T therapy for multiple myeloma, and GC019F, which targets adult B cell acute lymphoblastic leukemia and is also being investigated for relapsed or refractory B cell non-Hodgkin’s lymphoma. Additionally, Gracell is developing GC007F for B cell non-Hodgkin's lymphoma and GC027, an allogeneic CAR-T product candidate for adult T cell acute lymphoblastic leukemia. The company also has GC007g, a donor-derived therapy for relapsed or refractory B cell acute lymphoblastic leukemia, and a pipeline of earlier stage candidates targeting other cancer types, including ovarian cancer and breast cancer. Founded in 2017, Gracell aims to provide innovative cellular therapeutics that enhance treatment options for patients suffering from various hematological malignancies and solid tumors.

TrueLayer

Series C in 2020
TrueLayer Limited is a London-based company that provides an open banking platform enabling the development of financial applications. Founded in 2016, TrueLayer offers a toolkit that allows businesses to securely connect to bank data, verify accounts, and access real-time transaction information. Its platform supports various applications in payments, online lending, personal finance management, investment services, insurance, and cryptocurrencies. TrueLayer's solutions are utilized by fintech startups, online lenders, and personal finance managers, facilitating smarter and faster online payments by combining real-time bank transactions with financial and identity data. The company operates across 21 countries and serves over 10 million users, aiming to transform the payment landscape for businesses of all sizes.

BlueVoyant

Series C in 2020
BlueVoyant is a cybersecurity company founded in 2017 by former officials from U.S. Cyber Command and the National Security Agency. The company specializes in advanced threat intelligence, managed security services, and cybersecurity consulting, aiming to enhance the security posture of businesses and organizations. BlueVoyant's offerings include threat detection and response, vulnerability management, and proactive threat hunting. By combining human expertise with advanced technologies, the company addresses the evolving challenges posed by cyber threats. Its platform is designed to improve clients' cybersecurity defenses, providing increased visibility and professional insights to effectively detect, respond to, and remediate breaches and attacks.

Perfect Day

Series C in 2020
Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.

Arterys

Series C in 2020
Arterys Inc. is a technology company that specializes in developing a cloud-based analytics platform designed to enhance medical imaging diagnostics. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a range of artificial intelligence solutions, including Cardio AI for cardiac image analysis, Lung AI for lung imaging, and Liver AI for liver assessments. Their platform provides radiologists with tools to visualize and quantify blood flow in the human body, facilitating improved patient care through advanced imaging techniques. The Arterys PHI Service allows physicians to access patient data remotely, enhancing the efficiency of medical practice. As a pioneer in internet-based medical imaging, Arterys combines web accessibility with FDA-cleared AI technology to deliver innovative clinical solutions aimed at transforming healthcare.

Pivot Bio

Series C in 2020
Pivot Bio is improving and using a deep understanding of the microbiome to advance crop nutrition. They believe that microbes can deliver nutrients, protect against pests, and improve crop quality better than chemical fertilizers and pesticides. They leverage engineering principles and data science to map the dynamics of the plant microbiome and evolve beneficial traits. Their team thrives on collaboration and communication as they seek to create revolutionary fertilizers that transform food supply and improves the planet. Pivot Bio's proprietary ON Technology harnesses the power of naturally occurring microbes to provide more nutrients to crops. It’s a smart, sustainable way for farmers to improve yield as they work to help feed the world’s growing population. Their current efforts are focused on enabling microbes to fix and supply more nitrogen to corn. Pivot Bio was founded in 2010 and is headquartered in Berkeley, California, United States.

Alan

Series C in 2020
Alan is a provider of online digital insurance services that focuses on health and wellness. The company offers tailored health insurance solutions for various businesses, ensuring simple and seamless coverage. Alan facilitates easy claim handling and provides users with convenient access to medical professionals through both in-person and video consultations. This approach empowers individuals to manage their health more effectively while simplifying the process of obtaining medical advice and handling reimbursements.

Abbisko Therapeutics

Series C in 2020
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.

Kaishu Jianggushi

Series C in 2020
Kaishuo Jianggushi is a children's content provider. Also known as Kaishu Story, the brand is focusing on children’s stories with additional products such as audio series and online parenting courses.

Perfect Day

Series C in 2019
Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.

Provivi

Series C in 2019
Provivi Inc. specializes in developing biopesticides aimed at pest management in agriculture, commercial sectors, households, and public health. The company's innovative approach focuses on using insect pheromones, which provide a safe, environmentally friendly alternative to traditional pesticides. By leveraging biocatalysis technology initially developed at the California Institute of Technology, Provivi enhances the synthesis of these biopesticides, ensuring they are effective and free from toxic residues. Founded in 2013 and based in Santa Monica, California, the company collaborates with distributors worldwide to deliver its products, which are designed to protect food supplies sustainably and affordably. With a team of experienced professionals from biotechnology and the agricultural chemicals industry, Provivi is positioned to transform pest management practices through its advanced biological processes.

Avathon

Series C in 2019
Avathon is an artificial intelligence technology startup that specializes in developing AI solutions for industrial applications. The company is recognized for its cutting-edge technology, particularly its AI-powered cyber-physical software designed to enhance safety, security, and reliability across IT, operational technology (OT), and the Internet of Things (IoT). Avathon's technology leverages real-time sensor data, continuously learning from it to improve risk mitigation and prevention strategies, thereby averting potential disasters. Their cognitive software, DeepArmor, effectively prevents and detects malware using advanced machine learning techniques. Avathon aims to assist clients in analyzing complex data, enhancing decision-making, and boosting productivity in human and industrial contexts, with a strong emphasis on defense, industrial IoT, and financial sectors.

TrueLayer

Series C in 2019
TrueLayer Limited is a London-based company that provides an open banking platform enabling the development of financial applications. Founded in 2016, TrueLayer offers a toolkit that allows businesses to securely connect to bank data, verify accounts, and access real-time transaction information. Its platform supports various applications in payments, online lending, personal finance management, investment services, insurance, and cryptocurrencies. TrueLayer's solutions are utilized by fintech startups, online lenders, and personal finance managers, facilitating smarter and faster online payments by combining real-time bank transactions with financial and identity data. The company operates across 21 countries and serves over 10 million users, aiming to transform the payment landscape for businesses of all sizes.

Pear Therapeutics

Series C in 2019
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.

Genuity Science

Series C in 2018
Genuity Science is a company that specializes in clinco-omics data analysis solutions for researchers in the fields of central nervous system, cardiometabolic, and inflammatory diseases. The company provides a comprehensive global genomics platform that facilitates the study of biological data insights, offering services that include study design, genomic sequencing, data storage, interpretation, secondary analysis, and scalable analytics. By leveraging the human genome, Genuity Science aims to empower organizations to enhance patient health through advanced genomic insights and analysis.

Blaize

Series C in 2018
Blaize, Inc., founded in 2010 and headquartered in El Dorado Hills, California, specializes in edge AI processing solutions through its proprietary hardware architecture and low-code/no-code software platform. The company targets various industries, including automotive, retail, security, industrial automation, and healthcare, providing efficient solutions that address the challenges of edge AI processing, such as low latency and high thermal and power efficiency. Blaize's innovative approach overcomes limitations of traditional AI solutions, which are often optimized for data centers rather than edge environments. With a workforce of over 200 employees, the company has established teams in California, North Carolina, and international subsidiaries in India and the UK. Blaize has successfully raised over $200 million from a mix of strategic and financial investors, reinforcing its position as a leader in the AI-enabled edge computing market.

Orchard Therapeutics

Series C in 2018
Orchard Therapeutics is a biopharmaceutical company based in the United Kingdom that specializes in developing innovative gene therapies for serious and life-threatening rare diseases. The company employs an autologous ex vivo gene therapy approach, which modifies a patient's own hematopoietic stem cells to create a targeted treatment administered in a single dose. Orchard's portfolio includes Strimvelis, the first autologous gene therapy approved by the European Medicines Agency for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Additionally, it is advancing clinical programs for various conditions, including metachromatic leukodystrophy, Wiskott-Aldrich syndrome, X-linked chronic granulomatous disease, and transfusion-dependent beta-thalassemia. The company also has an extensive preclinical pipeline targeting mucopolysaccharidosis types I, IIIA, and IIIB. Orchard Therapeutics collaborates with leading institutions in gene therapy research, enhancing its efforts to transform the lives of patients with rare diseases in the UK, European Union, and the United States. Founded in 2015 and headquartered in London, it aims to provide sustainable clinical benefits through its innovative therapies.

Breather Products

Series C in 2018
Breather is an app and a provider of space-as-a-service, with a growing network of private workspaces built for productivity. It enables businesses to access flexible workspace by the hour, day, or month. Every space is designed to be comfortable, private, and productive, with plug-and-play technology that ensures that can get to work as soon as the arrival. Founded by CEO Julien Smith in 2012, the company has grown to include hundreds of locations in 10 major across the globe including New York, San Francisco, Los Angeles, and London.

Ant Group

Series C in 2018
Ant Group Co., Ltd. is a leading provider of digital payment and financial services in China, known for its flagship product, Alipay, a widely used digital payments platform. Established in 2000 and headquartered in Hangzhou, the company offers a variety of financial solutions, including Yu'e Bao, an online cash management platform that invests users' funds in a money market fund; Huabei, a consumer credit service facilitating buy now, pay later options; and MYbank, an online bank focused on serving small businesses and entrepreneurs. Additionally, Ant Group operates Xiang Hu Bao, a mutual aid platform for health protection, and Zhima Credit, a credit assessment service for businesses. The company aims to foster digital transformation across the service industry, ensuring that consumers and small enterprises have equal access to inclusive and sustainable financial services. In July 2020, it rebranded from Ant Small and Micro Financial Services Group Co., Ltd. to Ant Group Co., Ltd.

Akili Interactive

Series C in 2018
Akili Interactive is a digital medicine company focused on developing innovative cognitive treatments using technology. The company has a diverse pipeline of programs designed to address cognitive deficiencies and alleviate symptoms associated with various medical conditions. These include attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), and several inflammatory diseases. By leveraging engaging digital platforms, Akili aims to improve patient outcomes in the fields of neurology and psychiatry through its unique therapeutic approaches.

SenseTime

Series C in 2018
SenseTime Group Limited is an artificial intelligence company specializing in computer vision and deep learning technologies. Founded in 2014 and headquartered in Beijing, China, the company develops a wide range of AI solutions, including face and body analysis, image and video recognition, autonomous driving technologies, and medical image analysis. SenseTime's proprietary AI infrastructure, SenseCore, supports scalable and efficient AI software platforms tailored for various applications across sectors such as smart cities, intelligent transportation, healthcare, and finance. The company is also active in advancing industry standards related to data security and ethical AI practices, having contributed to numerous national and international guidelines. With a presence in multiple countries, including Japan, Singapore, and several locations in China, SenseTime aims to drive innovation and foster sustainable productivity through its AI technologies.

Zipline

Series C in 2018
Zipline Inc. is a California-based company that specializes in designing, manufacturing, and operating drones for the delivery of essential medical supplies, including vaccines, medicines, and blood. Founded in 2011 and headquartered in Half Moon Bay, the company aims to provide instant access to vital medical products for every individual globally. Since its inception, Zipline has developed a rapid delivery drone and an autonomous logistics network, allowing for efficient distribution to hospitals and health centers, particularly in remote areas. By leveraging its proprietary fixed-wing drone technology, Zipline facilitates timely deliveries that support the medical community and enhance patient care.

SES

Series C in 2017
SolidEnergy Systems Corp. develops and manufactures rechargeable lithium metal batteries primarily for applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and based in Woburn, Massachusetts, the company focuses on producing high-performance lithium metal batteries and supplying essential materials, such as anodes and electrolytes, to major lithium-ion cell manufacturers. These materials can be integrated into existing manufacturing processes, allowing for scalability without significant infrastructure investments. SolidEnergy's pilot-scale production caters to prototype demonstrations and specialized aerospace markets, while its future growth is aimed at mainstream sectors like consumer electronics and electric vehicles. Additionally, the company is involved in developing AI-powered safety algorithms and recycling solutions, positioning itself as an integrated battery manufacturer with a commitment to innovation and sustainability.

TrustDecision

Series C in 2017
TrustDecision, a fintech start-up based in Hangzhou, China, specializes in risk control services by offering online software solutions designed to combat theft and manage fraud. Founded in 2013, the company focuses on serving a range of sectors, including finance, insurance, payments, online shopping, and social networking. Through its innovative applications, TrustDecision aims to enhance security and mitigate risks for its clients in these industries.

Gogoro

Series C in 2017
Gogoro Inc. is a manufacturer of two-wheeled electric vehicles and a pioneering provider of battery swapping infrastructure, based in Taoyuan City, Taiwan. Founded in 2011, the company specializes in electric scooters, notably the Smartscooter, which features cloud connectivity and an electric powertrain that utilizes a network of swappable batteries. This modular battery swapping system allows urban riders to access portable power through strategically placed battery vending machines, facilitating the adoption of electric mobility in densely populated areas. Gogoro aims to transform megacities into smart cities by making energy distribution more efficient and accessible. The company's comprehensive ecosystem includes Gogoro Smart Batteries, GoStations, and battery management systems, contributing to a seamless integration of hardware and software. The majority of Gogoro's revenue is generated in Taiwan, where it has established a strong presence.

Neoway

Series C in 2017
Neoway is a market intelligence and big data analytics company founded in 2002 by Jaime de Paula and headquartered in Florianópolis, Brazil, with additional offices in São Paulo and New York City. The company specializes in helping businesses identify and capitalize on market opportunities through its subscription-based analytics platform, SIMM. This platform allows users to access detailed information about companies and individuals, visualize prospects geographically, manage opportunity distribution, and create alerts across various channels. Neoway serves a diverse range of industries, including automotive, healthcare, technology, and finance, offering valuable insights that enhance strategic decision-making for clients such as banks, insurance companies, and consumer goods firms.

ClassPass

Series C in 2017
ClassPass Inc. is an online fitness class booking service that offers a subscription model granting access to a wide network of boutique fitness studios and gyms. Established in 2011 and based in New York, the company connects members to over 25,000 partner locations globally, providing a diverse range of fitness options, including yoga, cycling, Pilates, boxing, and more. ClassPass enhances the member experience by utilizing machine learning to recommend classes from its extensive catalog, which features more than 5 million class offerings monthly. Additionally, the platform supports fitness studios by helping them manage excess inventory and attract new customers, ultimately fostering growth within the fitness industry.

LinkDoc

Series C in 2017
LinkDoc Technology Limited, founded in 2014 and headquartered in Beijing, China, specializes in medical data solutions and oncology-focused big data platforms. The company provides structured clinical data to oncology hospitals, aiding them in addressing various scientific and clinical challenges. Additionally, LinkDoc is committed to ensuring patient privacy and data security, adhering to standards set by the US HIPAA Act. The company focuses on delivering continuous care for patients with critical diseases and offers data-driven solutions that support life sciences companies and healthcare professionals in enhancing clinical research and facilitating real-world application of medical advancements.

G7

Series C in 2016
G7 is a provider and operator of fleet management systems that focuses on optimizing the transportation ecosystem in China. With an installation base of 800,000 cargo vehicles, the company utilizes proprietary hardware devices to gather critical data for logistics companies and drivers. Its platform enables businesses to monitor the location of trucks, track cargo status—including temperature and humidity—analyze fuel consumption, and record driver habits. By offering tools for route optimization and estimating departure and arrival times, G7 helps corporate clients and business owners enhance the efficiency of their transportation networks.

iTutorGroup

Series C in 2015
iTutorGroup is an online education provider founded in 1998, headquartered in Taipei City, Taiwan, with additional offices in Shanghai, China, and Santa Clara, California. The company offers a range of platforms designed for both students and business professionals, including VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English language learning, as well as TutorMing for Mandarin Chinese language instruction. Additionally, iTutorGroup provides LiveH2H, a service for live translations in multiple languages. The company focuses on delivering individualized and personalized learning experiences, allowing instructors to tailor content to meet the specific needs of learners.

Innovent Biologics

Series C in 2015
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.

Chunyu Yisheng

Series C in 2014
Chunyu Yisheng is a mobile application that enables physicians and their patients to communicate with each other. The application provides physicians with access to their patients’ medical records. Furthermore, it enables the patients to communicate and schedule appointments with the doctors. In addition, it offers reservation line treatment services to its users. Chunyu Yisheng was launched in 2011 by Rui Zhang and is based in Beijing.

FirstCry India

Series C in 2014
FirstCry is an online portal for baby products and toys. They have over 20000+ items from 250+ top International and Indian brands like Mattel, Ben10, Pigeon, Funskool, Hotwheels, Nuby, Farlin, Medela, Pampers, Disney, Barbie, Gerber, Zapak, Mee Mee, and so on. The company provides best of the products and brands at the best prices with quality online shopping experience, fast and reliable delivery service, and a prompt customer care. FirstCry was founded in 2010 and is based in Pune, India.

Xiaomi Technology

Series C in 2012
Xiaomi Corporation is a technology company headquartered in Beijing, China, founded in 2010. It specializes in manufacturing and marketing smartphones, consumer electronics, and Internet of Things (IoT) products. Xiaomi operates through several segments, including Smartphones, IoT and Lifestyle Products, Internet Services, and Others. The Smartphones segment includes a range of Android-based devices, while the IoT and Lifestyle Products segment features smart TVs, laptops, AI speakers, and various smart hardware. Additionally, Xiaomi provides Internet services such as advertising and value-added services. The company has expanded its presence internationally and is a leading smartphone brand in India and increasing its market share in Europe. Xiaomi is known for its commitment to innovation and customer feedback, which informs its product development. It sells its products through online platforms and retail stores across multiple countries.

Harbour Networks Holdings

Series C in 2005
Harbour Networks Holdings was acquired by Huawei Technologies Co. Ltd. The company provides Internet protocol-based networking equipment. The company offers Ethernet switches, IP core and edge routers, broadband access equipment, voice over Internet protocol products, optical transport platforms, and networking and services management software, as well as ADSL/VDSL broadband access equipment and NGN integrated access equipment. It serves telecom carriers, corporations, education and government institutions, government agencies, finance, power, and service industries in China, North America, Japan, Hong Kong, and Southeast Asia. The company was founded in 2000 and is based in Beijing, China. As of September 11, 2006, Harbour Networks Holdings Limited operates as a subsidiary of Huawei Technologies Co., Ltd.

BioVex Group

Series C in 2003
BioVex is a biotechnology company dedicated to developing and commercializing biological therapies for cancer treatment and the prevention of infectious diseases. Its primary focus is OncoVEXGM-CSF, an oncolytic vaccine that selectively targets and destroys cancer cells while sparing surrounding healthy tissue. This vaccine operates by replicating within solid tumors, leading to cancer cell death, and also stimulates a robust systemic immune response against tumors. OncoVEXGM-CSF has undergone clinical testing in over 110 patients across various solid tumors, including melanoma, head and neck cancer, breast cancer, and pancreatic cancer. The treatment has demonstrated significant efficacy, routinely eliminating tumors at the injection site and achieving overall disease responses during Phase II trials, with no reported recurrences of resolved tumors. Additionally, BioVex is developing ImmunoVEXHSV2, a vaccine aimed at preventing genital herpes.

Semiconductor Manufacturing International

Series C in 2003
Semiconductor Manufacturing International Corporation (SMIC) is a leading semiconductor foundry based in Shanghai, China, established in 2000. It specializes in the design and manufacturing of integrated circuits (IC) and offers a comprehensive range of services including computer-aided design, wafer fabrication, testing, packaging, and assembly. SMIC operates advanced fabrication facilities, including 300mm and 200mm fabs in various locations such as Beijing, Tianjin, and Shenzhen, and provides technology services for process nodes ranging from 0.35 microns to 28 nanometers. The company serves a diverse clientele, including integrated device manufacturers, fabless semiconductor firms, and system companies, with its products utilized in sectors such as artificial intelligence, data centers, automotive, consumer electronics, and the Internet of Things. SMIC is recognized as the largest foundry in China and ranks fifth globally in the semiconductor industry, employing over 20,200 people and maintaining a presence in markets across North America, Europe, Japan, and Taiwan.

Orqis Medical

Series C in 2003
ORQIS Medical Corporation operates as a medical device company. It develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. It offers Cancion System, a heart failure treatment that uses continuous aortic flow augmentation technology to improve symptoms of heart failure and change the underlying course of the disease for patients hospitalized for de-compensated heart failure. The company’s products also include Exeleras System to treat chronic heart failure patients.

Anesiva

Series C in 2002
Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

Savi Technology

Series C in 2001
Savi is the leader in applying big data analytics, data science, and machine learning to in-transit visibility. We develop innovative Internet of Things (IoT) and in-transit visibility solutions for the largest and most complex supply chains in the world. More than 1,000 companies and government organizations depend on Savi applications to reduce supply chain disruptions, improve delivery performance, and decrease logistics costs. For more information about Savi visit www.savi.com.

Paypal

Series C in 2000
PayPal is a leading provider of electronic payment solutions, facilitating online transactions for both merchants and consumers. Established over 20 years ago and spun off from eBay in 2015, PayPal has grown to support 426 million active accounts across more than 200 markets worldwide. The platform empowers users to make and receive payments, transfer funds, and withdraw money securely and conveniently. Additionally, PayPal owns Venmo, a widely used person-to-person payment service. The company is committed to enhancing the financial technology landscape, offering tools and resources that promote entrepreneurship and innovation in digital payments. Through strategic investments and initiatives, PayPal aims to create a more transparent, inclusive, and customer-focused global financial system.

DoveBid

Series C in 2000
DoveBid, Inc. provides capital asset auction, valuation, redeployment, and management services for corporations, government agencies, and financial institutions worldwide. It offers a portfolio of asset disposition solutions that includes live Webcast auctions, online auctions, sealed bid Internet sales, and private treaty Internet sales. The company also provides appraisal and surplus asset management services, as well as leasing, shipping, and transaction support services. It serves various clients, including biotech, medical, pharmaceutical, chemical and petroleum, computers, peripherals, data processing, construction, mining, farming, consumer electronics, consumer goods and inventory, defense and aerospace, food and beverage, iron and steel, office furnishings and equipment, packaging and converting, plastics and rubber, power and electric, printing, semiconductor fabrication, telecommunications, textile and apparel manufacturing, and woodworking and mills, as well as vehicles, boats, and commercial transportation clients. DoveBid, Inc. was founded in 1937 as Dove Mercantile Co. and changed its name to Ross-Dove Co. Further, Ross-Dove Co. was renamed to DoveBid, Inc. The company is based in Culver City, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.